本文關(guān)鍵詞： 穴位埋線 單純性肥胖 周期 可吸收性外科縫線　出處：《嶺南急診醫(yī)學(xué)雜志》2017年01期 　論文類型：期刊論文

【摘要】：目的:觀察不同穴位埋線周期對單純性肥胖患者的治療效果。方法:將60例符合納入標(biāo)準的單純性肥胖患者按照隨機數(shù)字表法隨機分為A組,B組,C組三組,每組各20例,穴位埋線治療周期分別為7 d、14 d、21 d,均以42 d為1療程,共治療兩個療程。觀察三組患者治療前及治療2個療程后體重(%)、體重指數(shù)(BMI)、脂肪分布率(F%)、不良反應(yīng)出現(xiàn)率。結(jié)果:經(jīng)過治療后,三組治療后體重下降(%)、脂肪分布率、體重指數(shù)均較治療前明顯下降(P0.05);A組與B組各項指標(biāo)下降較C組明顯(P0.05)。從治療療效來看,A組、B組、C組的總有效率分別為85.00%、90.00%、55.00%。從不良反應(yīng)的出現(xiàn)率來看:A組、B組、C組的不良反應(yīng)出現(xiàn)率分別為50.00%、15.00%、10.00%。結(jié)論:結(jié)合療效和不良反應(yīng)率,采用可吸收外科縫線進行穴位埋線治療單純性肥胖的最佳周期以14天為宜。
[Abstract]:Objective: to observe the effect of catgut embedding at different acupoints on patients with simple obesity. Methods: 60 patients with simple obesity were randomly divided into group A and group B according to random digital table. In group C, 20 cases in each group were treated with catgut embedding at acupoint for 7 days, 14 days and 21 days respectively, 42 days as a course of treatment. Two courses of treatment were used to observe the body weight, body mass index (BMI), fat distribution rate and adverse reaction rate before and after 2 courses of treatment in the three groups. Results: after treatment. After treatment, the weight loss, fat distribution rate and body mass index in the three groups were significantly lower than those before treatment. The indexes of group A and group B were significantly lower than those of group C (P 0.05). The total effective rate of group A and group B was 85.00% and 90.00%, respectively. According to the incidence rate of adverse reactions, the incidence of adverse reactions in group B and group B was 50.00,15.00%, respectively. Conclusion: combined with curative effect and adverse reaction rate, the best period for the treatment of simple obesity with absorbable surgical suture is 14 days.
【作者單位】： 福建省福建中醫(yī)藥大學(xué)附屬第三人民醫(yī)院;
【基金】：福建中醫(yī)藥大學(xué)校管課題(XB2015024)
【分類號】：R246.1
【正文快照】： 單純性肥胖是一種多因素的慢性代謝性疾病。目前,單純性肥胖的常見治療方法有針灸治療、埋線治療、藥物治療等。其中,穴位埋線治療是最常見的方法。通過臨床觀察發(fā)現(xiàn)不同周期的穴位埋線治療,效果有較大的差異,且不同周期埋線治療出現(xiàn)不良反應(yīng)的情況也存在很大的差異。 臨床上

【參考文獻】

相關(guān)期刊論文 前7條

1 聶紅f ;梁欣;侯s閎，

本文編號：1491761